Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 148.42% | 150.00% | 187.02% | -93.46% | -16.30% |
Total Depreciation and Amortization | 37.19% | 29.90% | 1.50% | 9.07% | 8.33% |
Total Amortization of Deferred Charges | 120.00% | 93.85% | 41.15% | 1.68% | 38.30% |
Total Other Non-Cash Items | -82.76% | 221.48% | -147.37% | 61.24% | 188.91% |
Change in Net Operating Assets | 182.07% | -191.20% | -36.57% | 204.37% | -25.72% |
Cash from Operations | 278.28% | -90.25% | -22.08% | 40.47% | 82.27% |
Capital Expenditure | 20.40% | 28.62% | -28.18% | -20.03% | -23.05% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -2,493.18% | -8,643.99% | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -187.38% | 460.95% | 184.47% | 550.41% | 136.21% |
Cash from Investing | -1,715.13% | -947.72% | 80.91% | 11.39% | 102.99% |
Total Debt Issued | 30.65% | 1,045.24% | 1,011.76% | 38.91% | 93.75% |
Total Debt Repaid | -101.61% | -294.92% | -1,243.27% | -30.72% | -97.75% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.10% | 0.02% | 0.00% | 0.00% | 0.02% |
Other Financing Activities | -258.12% | -11.85% | -608.57% | -- | -- |
Cash from Financing | -763.84% | 1,979.09% | -2,352.85% | 128.22% | 1,609.15% |
Foreign Exchange rate Adjustments | 537.96% | -69.47% | 369.00% | -271.12% | -374.00% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -138.95% | 249.63% | -1,102.99% | 404.28% | 155.33% |